Masimo Corporation MASI recently announced the FDA clearance of its Masimo SET-powered MightySat Medical Pulse Oximeter, available Over-The-Counter (OTC) to consumers without a prescription.

Masimo Corp. and Apple Inc. have filed dueling post-trial briefs in a California federal court, following a retrial over ...

In late 2023, Apple received a small blow to its lucrative Christmas sales period thanks to the medical device manufacturer ...

Masimo sells a range of devices used for patient monitoring that feature a proprietary pulse oximetry technology called Signal Extraction Technology (SET). In the latest update on that patent spat ...

Pulse oximetry is increasingly being used for remote and self-monitoring of blood oxygen in wearables, and Masimo sells a range of devices for patient monitoring purposes, including a recently ...

Masimo SET ® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry ...

Shares of Masimo Co. (NASDAQ:MASI – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the seven brokerages that are presently covering the stock, Marketbeat Ratings ...

Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry ...

Masimo (NASDAQ:MASI – Get Free Report) had its price objective raised by equities research analysts at Raymond James from ...

IRVINE, CA and WASHINGTON, DC--(Marketwired - Dec 6, 2013) - Masimo (NASDAQ: MASI) today announced the launch of iSpO 2 ™ Rx Pulse Oximeter with M-LNCS™ connector, enabling adhesive sensor use ...

Masimo (NASDAQ: MASI) today announced that its management will participate in the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 10:30 a.m. Pacific time. A live webcast ...